Position in HIMS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$27,372,415
+$16,814,398 QoQ
Shares Held
789,513
+55.2% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#29
of 504 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $58,181,394 across 12 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
This page
|
789,513 | $27,372,415 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,634,336 | $16,343,360 | |
| 3 | ZTS |
Zoetis Inc.
|
67,756 | $4,868,946 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,521 | $3,533,273 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
36,515 | $1,237,128 | |
| 6 | PRGO |
PERRIGO Co plc
|
111,868 | $1,162,308 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
10,061 | $1,116,167 | |
| 8 | ALKS |
Alkermes plc.
|
20,383 | $1,068,069 |
All Filings in HIMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,372,415 | 789,513 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $10,558,017 | 508,575 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $7,756,920 | 238,895 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $9,817,324 | 173,084 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $762,555 | 15,297 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $7,082,425 | 239,676 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,175,668 | 172,691 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,192,989 | 64,766 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,492,425 | 172,978 | Shares | Sole | 2024-07-15 | |
| No filing history on record for this holder in this stock. | ||||||